← Evidence map

ArticleNeuro-oncology2015

Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.

Melissa M Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

45 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25795306